"AI-First" Hype Gives Way to Reality: New Speechmatics Report Reveals What's Actually Working in AI
As the AI gold rush slows, a new report from Speechmatics explores what's actually working — and where the real value lies.
Titled The Voice AI Reality Check: Frontline Perspectives for Enterprise in 2025, the report zeroes in on one of the fastest-evolving areas of AI: Voice AI.
Built on interviews with leaders across healthcare, compliance, media, public services, and research, it reveals a clear shift from flashy demos to embedded, operational AI — where tools assist humans, deliver measurable ROI, and quietly power core infrastructure.
Report highlights include:
Assistive over autonomous: The most effective deployments augment people rather than replace them. Assistive agents are driving real ROI.
Multilingual as standard: Real-time code-switching is now a baseline requirement, not a bonus.
Accuracy is make-or-break: With growing global concerns over AI hallucinations, precision is essential — especially in compliance-heavy environments.
Voice as infrastructure: Quietly embedded tools are outperforming headline-grabbing features.
Rather than betting on speculative demos, successful enterprises are treating Voice AI as critical infrastructure. It's being embedded into workflows that demand speed, accuracy, and trust — from noisy control rooms to multilingual contact centres.
The report closes with future-looking predictions, outlining the rise of emotionally intelligent, adaptive, and natively multilingual voice systems — and offers guidance on what enterprises must prioritise next.
Download the full report now.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250603560526/en/
Contacts
For interviews, images, quotes or media access, contact: Mieke Kyra, Content Lead mieke.smith@speechmatics.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Wall Street sees stock market rotation charting 'healthiest path' to new highs
The stock market's rally to record highs has started to suggest some investors see life outside of the Big Tech names that have defined markets since 2023, as lagging sectors like Health Care (XLV) and Homebuilders (XHB) — as well as out-of-favor investments like small- and mid-cap stocks — have played a larger role in this summer's move. And some strategists see this rotation as an early sign that an even healthier market dynamic could be emerging. Scott Chronert, managing director of US equity strategy at Citi, sees this broader participation as framing out "two parallel paths" for the S&P 500 — one led by the AI-fueled growth giants and the other driven by more traditional sectors tied to the economy. "The simple answer is that we see ongoing Mega Cap Growth participation, if not leadership, but with fundamental and performance broadening creating a more durable structural setup," he said on Friday. "The healthiest path to higher index levels is a combination of Growth/Tech leadership persisting but with other areas of the market additive more so than has been the case this past year." Data from Bespoke Investment Group published Friday noted investors last week showed signs of moving out of 2025's biggest winners and into less-loved pockets of the market. Over the middle three trading days last week, Bespoke's work found stocks in the worst-performing decile this year among S&P 1500 companies were up an average of 6.7%; the best performers were up less than 1% over the same period. "When momentum names stall or sell-off, it can really hit the major indices hard if no other areas of the market are there to pick up the slack," Bespoke said. "But [last] week, the year's worst performers finally saw some buying interest as investors rotated across the market instead of out of it." Ed Yardeni of Yardeni Research added that rising expectations for a September Fed rate cut helped fuel the shift, sparking a rotation from growth to value and from large caps to small- and mid-cap stocks. "We certainly welcome such a broadening," he wrote in a Sunday note to clients. 'Significant headwinds' remain Sean Simonds, US equities strategist at UBS, described the current broadening setup as "a mixed bag," noting that AI-driven momentum is starting to spill into other adjacent areas like software, power, and re-shoring. Simonds added that after a wave of downward earnings revisions earlier this year, earnings breadth has also shown signs of improving. However, areas such as consumer and healthcare remain weaker, even if the outlook there has turned "less negative." Gerry Fowler, head of European equity strategy at UBS, added that small-cap stocks in particular depend on a 'Goldilocks' scenario in which the Fed manages to cut rates without spooking markets. "If Powell is able to stay out of the headlines and deliver the September cut in line with expectations, there is room for the broader market to remain quite healthy," Fowler said. "On either side of Goldilocks, you've got significant headwinds for the Russell 2000." Read more: How the Fed rate decision affects your bank accounts, loans, credit cards, and investments Fowler's cautious note echoes a broader concern on Wall Street, which is that signs of rotation among styles and sectors overstate the extent to which this shift sees investors actually preferring to put more money behind new themes. DataTrek Research noted in a recent report that just two of the S&P 500's 11 sectors — Technology (XLK) and Industrials (XLI) — have outperformed since the index's April lows. The firm also noted that the top 20 names in the index, or nearly half the S&P 500 on a market cap basis, are up more than 40% on average over that period. That concentration means the durability of the rally may hinge on whether new pockets of strength can sustain recent momentum. Looking ahead, Simonds cautioned that momentum could stall if earnings expectations fade or if the Fed delivers a surprise that clashes with market expectations. "There's still the possibility of earnings expectations slowing into the second half of this year and first half of next year," he said. 'And any disappointment out of Jackson Hole or into the September Fed meeting will definitely take some wind out of the sails as well." Allie Canal is a Senior Reporter at Yahoo Finance. Follow her on X @allie_canal, LinkedIn, and email her at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNET
29 minutes ago
- CNET
Is Ultrahuman's Ring Air Now the Most Accurate Ovulation-Tracking Smart Ring?
Ultrahuman's new Cycle and Ovulation Pro feature for the Ring Air has an unexpected origin story. The algorithm behind it was originally designed for intravaginal fertility monitors, but Ultrahuman has since turned it into a non-invasive, temperature-sensing tool that can track ovulation right from your finger. The wearable health tech company announced on Friday that it acquired viO HealthTech, which created the OvuSense algorithm. Validated in 13 peer-reviewed clinical publications and backed by 15 years of clinical research, the algorithm draws on data from over 260,000 cycles collected with medical-grade sensors. It was previously used in class II intravaginal medical fertility monitors. Now, Ultrahuman has adapted that technology for wellness tracking to create its Cycle and Ovulation Pro PowerPlug for the Ring Air. How accurate is Ultrahuman's Cycle and Ovulation Pro? In a press release, Ultrahuman said Cycle and Ovulation Pro delivers over 90% accuracy in confirming ovulation -- a level the company said makes the Air the "world's most accurate cycle-tracking smart ring." This data comes from equivalence testing that compared OvuSense and Ring Air with a multi-hormone ovulation prediction method that tracks rises in luteinizing hormone and progesterone. Though other cycle trackers may report different ovulation confirmation rates -- for example, the Oura Ring claims 96.4% -- that data isn't directly comparable to OvuSense and Ring Air's testing due to differences in validation protocols, datasets and definitions of detection. Ultrahuman Most platforms that track menstrual cycles rely on a 28-day cycle, but Cycle and Ovulation Pro takes into consideration that 87% of people who menstruate have varying cycles due to conditions such as polycystic ovary syndrome, endometriosis, non-bleeding, thyroid disorders or irregular bleeding. "This collaboration benefits from 15 years of clinically proven women's health expertise and applies it to the world's lightest smart ring," said Mohit Kumar, Ultrahuman CEO, in the press release. "For the first time, best-in-class hardware, software and algorithms with a clinical background come together in one wellness device. Our mission is to give women cutting-edge tools to optimize their health, combining clinical technology with comfort and style to deliver the most accurate women's health tool available." How is Pro different from the free Cycle and Ovulation PowerPlug? Cycle and Ovulation Pro complements Ultrahuman Ring Air's existing free Cycle and Ovulation PowerPlug, which provides basic conception and cycle tracking. Using physiological patterns and temperature biomarkers passively captured by the smart ring, the Pro version can support fertility planning, offer a space for mood, symptom and behavior logging and use temperature data to suggest hidden patterns in a cycle. Known as Cycle Flags, these patterns may include early, late or absent ovulation, a short luteal phase and trends potentially linked to conditions such as PCOS or miscarriage risk. Ultrahuman A note on FDA clearance While the OvuSense algorithm is FDA-cleared for intravaginal use, the adapted, non-invasive version for the Ultrahuman Ring Air was created for general wellness and isn't FDA-cleared. In other words, the Ring Air isn't a substitute for contraception or for professional medical diagnosis and treatment. For those, you should consult your health care provider. Cycle and Ovulation Pro cost Now available in the US, UK, EU, Australia and Canada, Cycle and Ovulation Pro is a premium PowerPlug in the Ultrahuman app that costs $3.99 per month or $39.99 per year. The current Cycle and Ovulation PowerPlug remains free.
Associated Press
30 minutes ago
- Associated Press
Atalanta signs Poland wing-back Nicola Zalewski after short stay at Inter Milan
BERGAMO, Italy (AP) — Atalanta has signed Nicola Zalewski with the Poland wing-back leaving Inter Milan after just seven months and 17 games, including a Champions League final. Atalanta did not disclose a transfer fee in the deal announced late Monday for the 23-year-old Zalewski. It was reported to be 17 million euros ($20 million). That would be about 10 million euros ($11.7 million) profit for Inter which signed Zalewski on loan from Roma in February. The move was made permanent with a 6.3 million euro ($7.4 million) deal in June, while the club was in the United States at the Club World Cup. Inter lost in the round of 16 against Fluminense. Zalewski will stay in the Champions League this season after Atalanta qualified by placing third in Serie A. In the final last season, he came on as a second-half substitute in Inter's 5-0 loss against Paris Saint-Germain. The Italy-born Zalewski has played 29 times for Poland including two games at the 2022 World Cup in Qatar and two at the 2024 European Championship in Germany Atalanta said Zalewski is its fifth offseason signing for the club, which is majority-owned by United States investor Stephen Pagluica. The team is now coached by Ivan Jurić after the inspirational Gian Piero Gasperini left to join Roma after nine years in Bergamo that brought the 2024 Europa League title. ___ AP soccer:
